Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry.
Spirito A, Koh WJ, Sartori S, Vogel B, Feng Y, Baber U, Nicolas J, Snyder C, Kamaleldin K, Pileggi B, Rezvanizadeh V, Sweeny J, Sharma SK, Kini A, Pocock SJ, Dangas G, Mehran R.
Spirito A, et al. Among authors: koh wj.
Am Heart J. 2023 Sep;263:26-34. doi: 10.1016/j.ahj.2023.04.007. Epub 2023 Apr 23.
Am Heart J. 2023.
PMID: 37094668